Is AMPL a Buy or a Sell? The Bull and Bear Case (2026)
Last updated October 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for Amplitude (AMPL) rests on Statsig and the experimentation upsell: The May 2026 partnership with OpenAI handed Amplitude Statsig's brand, its commercial customer base and responsibility for running and developing the platform, while the original Statsig team stayed at OpenAI. The bear case rests on valuation risk is now the obvious one: the shares moved from ~$5.51 in April to ~$17 in October, so a soft November print or cautious 2027 commentary could reverse part of that quickly, as the 21% one-day drop on May 7, 2026 showed. Analysts covering it publish targets from $11.00 to $19.00 against a $17.27 price, so even the professionals disagree by 52% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
Amplitude, Inc. sells a cloud platform that shows companies how people use their digital products. A team at a bank, a streaming service or a retailer drops Amplitude's code into its app or website, and the software records events such as sign-ups, clicks and purchases, then turns them into funnels, retention curves and cohort charts. Around that core analytics product it now sells experimentation and feature flags, session replay, guides and surveys, a customer data platform, and a set of AI agents that watch dashboards and flag changes on their own. The company was founded in 2011 by Spenser Skates (still CEO), Curtis Liu and Jeffrey Wang, listed on Nasdaq through a direct listing in 2021, and has ~780 employees and more than 5,200 paying customers. The last two quarters changed the growth picture. Revenue for full-year 2025 was ~$343 million, up 15%. In the second quarter of 2026 (reported August 5), revenue reached ~$100.9 million, up 21%, and annual recurring revenue (ARR) hit ~$410 million, up 22%. About $17 million of that ARR came from Statsig, the experimentation platform OpenAI bought in 2025 whose commercial customers and brand Amplitude took over in a May 2026 partnership. Remaining performance obligations rose 35% to ~$483 million and customers paying over $100,000 a year grew 30% to 824. The cost side moved the other way: non-GAAP gross margin slipped to ~71% on AI inference, hosting and Statsig integration costs, and the GAAP operating loss widened to ~$35 million. The investment picture is a sharp turn in sentiment. The stock fell to ~$5.51 in April and closed at ~$5.91 on May 7 after a first-quarter report that cut profit guidance. It then nearly tripled into late October, helped by the Statsig deal, the Q2 acceleration, heavy buybacks (~$89 million in the first half) and price-target increases from BTIG and BofA. At ~$17.24 and ~124.9 million shares, the market cap is ~$2.15 billion and the enterprise value about ~$2.0 billion, roughly 5x 2026 revenue guidance. Third-quarter results arrive on November 4, 2026.
The bull case: what would have to be true for $19.00
The most optimistic published target on AMPL is $19.00, +10.0% from the $17.27 price as of October 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.
1. Statsig and the experimentation upsell
The May 2026 partnership with OpenAI handed Amplitude Statsig's brand, its commercial customer base and responsibility for running and developing the platform, while the original Statsig team stayed at OpenAI. It added ~$17 million of ARR in the second quarter alone, and in October Statsig's founder, Vijaye Raji (now OpenAI's CTO of Applications), joined Amplitude's board. The bet is that pairing analytics with experimentation and feature flags lets Amplitude sell a single system for deciding what to build, shipping it and measuring it. If Statsig customers stay and adopt Amplitude analytics, the deal lifts both ARR and net retention; if they drift to rivals, the ARR boost fades.
2. AI agents and the MCP connection
Amplitude now describes itself as an AI analytics company. It launched a Global Agent that answers questions across a customer's data, specialized agents that monitor dashboards, experiments, session replays and feedback, an AI Feedback product, and a Model Context Protocol server that pushes Amplitude data into Claude, Cursor, Slack and Figma. The commercial question is whether these features raise prices per seat or per event, or simply become table stakes. Management has tied part of the 2026 gross margin decline to inference costs, so the agents need to show up in revenue, not only in product demos, for the spending to pay back over the next several quarters.
3. Enterprise expansion and backlog
Growth is concentrating in larger accounts. Customers paying more than $100,000 a year rose 30% to 824 in the second quarter, up from 698 at the end of 2025, and the number above $1 million was 56 at year-end 2025, up 33%. Remaining performance obligations of ~$483 million grew 35%, faster than revenue, which points to longer and larger contracts. Dollar-based net retention, however, is still modest at ~103% for the quarter and ~105% trailing, below the 110% to 120% levels many software investors look for. Lifting that figure through cross-selling replay, experimentation and agents is the main lever for organic growth beyond the Statsig contribution.
4. Margins, cash flow and buybacks
Amplitude produces more cash than its GAAP losses suggest. Free cash flow was a record ~$23.5 million in 2025 and ~$23.7 million in the second quarter of 2026 alone. Management guides 2026 non-GAAP operating income to only ~$6 million to $9 million on revenue of ~$407 million to $411 million, so profit is thin and depends on how fast AI and Statsig costs come down. The company carries no debt and held ~$161 million of cash and securities in June, after spending ~$89 million on repurchases in the first half and adding a $100 million authorization in February. Stock-based compensation remains large, which is why GAAP losses persist.
The bear case: what would have to be true for $11.00
The most pessimistic published target is $11.00, -36.3% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Amplitude is worth if the risks below bite instead of the drivers above.
Valuation risk is now the obvious one: the shares moved from ~$5.51 in April to ~$17 in October, so a soft November print or cautious 2027 commentary could reverse part of that quickly, as the 21% one-day drop on May 7, 2026 showed. Organic growth is harder to read because Statsig flatters ARR; strip out its ~$17 million and the underlying business grew closer to the high teens. Gross margin has fallen into the ~68% to 71% range on hosting, inference and integration costs, and if AI usage keeps rising faster than pricing, profitability guidance could be cut again, which is what happened in May. Competition is intense from free and cheap tools (Google Analytics, PostHog), from enterprise suites (Adobe, Contentsquare), and from warehouse-native analytics built on Snowflake and Databricks. Large language models also threaten to commoditize dashboarding itself. GAAP losses (~$35 million last quarter) rely on heavy stock compensation, insiders including the CEO's household have been selling under 10b5-1 plans, and a law firm announced an investigation after the May drop, although no 2026 class action complaint had been found as of October 2026.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding AMPL already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on AMPL
11 analysts cover AMPL, with an average target of $15.36 (-11.1% against $17.27) and a split of 9 buy, 3 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the AMPL forecast and price target page.
How is AMPL valued? (as of October 2026)
Snapshot for AMPL as of October 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~$374M
- ARR (Q2 2026): ~$410M (+22%)
- Market cap: ~$2.15B
- Share price: ~$17.24
- EV / 2026 revenue guide: ~4.9x
- Free cash flow (Q2 2026): ~$23.7M
Amplitude has no meaningful GAAP earnings, so revenue multiples carry the valuation. Subtracting ~$161 million of cash and securities from a ~$2.15 billion market cap gives an enterprise value of ~$2.0 billion, about ~4.9x the ~$409 million midpoint of 2026 revenue guidance and ~5.3x trailing revenue. That is up from roughly 1.5x to 2x in April, when the stock sat near $6. Non-GAAP EPS guidance of ~$0.06 to $0.08 for 2026 implies a forward multiple above 200x, so the price rests on growth and cash flow, not current earnings.
How do you decide if AMPL is a buy?
Rather than asking whether AMPL is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold AMPL indirectly through an index or sector ETF before adding more.
What would change your mind on AMPL
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: Statsig and the experimentation upsell stalls in the reported numbers rather than in the narrative around them.
- Bear case breaks if: valuation risk is now the obvious one: the shares moved from ~$5.51 in April to ~$17 in October, so a soft November print or cautious 2027 commentary could reverse part of that quickly, as the 21% one-day drop on May 7, 2026 showed fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the AMPL stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about AMPL against your real portfolio and see your actual exposure before deciding.
Investing in Amplitude with AI
Connect the broker you already use and ask Walnut's AI how AMPL fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
Is AMPL a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on Statsig and the experimentation upsell, with revenue (ttm) at ~$374M. The bear case rests on valuation risk is now the obvious one: the shares moved from ~$5.51 in April to ~$17 in October, so a soft November print or cautious 2027 commentary could reverse part of that quickly, as the 21% one-day drop on May 7, 2026 showed. Analysts covering it are spread from $11.00 to $19.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.
Should I sell AMPL?
+
Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Valuation risk is now the obvious one: the shares moved from ~$5.51 in April to ~$17 in October, so a soft November print or cautious 2027 commentary could reverse part of that quickly, as the 21% one-day drop on May 7, 2026 showed. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $11.00, -36.3% from the $17.27 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.
What is the bull case for AMPL?
+
Statsig and the experimentation upsell. The May 2026 partnership with OpenAI handed Amplitude Statsig's brand, its commercial customer base and responsibility for running and developing the platform, while the original Statsig team stayed at OpenAI. The most optimistic analyst target on AMPL is $19.00, +10.0% from the $17.27 price. That figure is only reachable if this thesis works close to its best case.
What is the bear case for AMPL?
+
Valuation risk is now the obvious one: the shares moved from ~$5.51 in April to ~$17 in October, so a soft November print or cautious 2027 commentary could reverse part of that quickly, as the 21% one-day drop on May 7, 2026 showed. Organic growth is harder to read because Statsig flatters ARR; strip out its ~$17 million and the underlying business grew closer to the high teens. Gross margin has fallen into the ~68% to 71% range on hosting, inference and integration costs, and if AI usage keeps rising faster than pricing, profitability guidance could be cut again, which is what happened in May. Competition is intense from free and cheap tools (Google Analytics, PostHog), from enterprise suites (Adobe, Contentsquare), and from warehouse-native analytics built on Snowflake and Databricks. Large language models also threaten to commoditize dashboarding itself. GAAP losses (~$35 million last quarter) rely on heavy stock compensation, insiders including the CEO's household have been selling under 10b5-1 plans, and a law firm announced an investigation after the May drop, although no 2026 class action complaint had been found as of October 2026. The most pessimistic published target is $11.00, -36.3% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.
What does Amplitude do?
+
Product analytics software company that shows digital businesses how people use their apps and websites, now adding experimentation and feature flags.
What would have to change for AMPL to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Statsig and the experimentation upsell) stalling in the reported numbers rather than in the narrative, the risk above (valuation risk is now the obvious one: the shares moved from ~$5.51 in April to ~$17 in October, so a soft November print or cautious 2027 commentary could reverse part of that quickly, as the 21% one-day drop on May 7, 2026 showed) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
What does Amplitude actually do?
+
Amplitude sells software that tracks how people use a company's app or website and turns those events into charts that product, marketing and engineering teams can act on. A typical customer sees where users drop out of a sign-up flow, which features keep people coming back, and how a change affected revenue. Beyond core analytics, the platform includes experimentation and feature flags (now including Statsig), session replay, in-app guides and surveys, a customer data platform, and AI agents that monitor metrics and answer questions in plain language. It sells on annual and multi-year subscriptions, mostly priced on data volume and modules, to more than 5,200 paying customers, including 824 that each pay more than $100,000 a year as of June 2026.
Why did AMPL stock almost triple in 2026?
+
The stock started from a very low base. It hit ~$5.51 in April 2026 and closed at ~$5.91 on May 7 after a first-quarter report cut 2026 non-GAAP operating income guidance to ~$2.5 million to $6.5 million from ~$7 million to $13 million, and BofA downgraded the shares. Several things then turned. The Statsig partnership with OpenAI added customers and ARR, second-quarter revenue growth accelerated to ~21% with ARR up ~22%, profit guidance was lifted back to ~$6.3 million to $9.3 million, and the company bought back ~$69 million of stock in that quarter alone. By late October analysts at BTIG and BofA had raised price targets to $17 and $19, and the stock was trading near a 52-week high of ~$17.72.
What is the Statsig deal and why does it matter?
+
Statsig is an experimentation and feature-flag platform that OpenAI agreed to buy for ~$1.1 billion in stock in September 2025. In May 2026, Amplitude announced a strategic partnership under which it takes on Statsig's brand and commercial customers and maintains and develops the platform, while the Statsig team stays at OpenAI and OpenAI keeps using the technology internally. Amplitude has not disclosed a purchase price in the filings reviewed here. The deal added ~$17 million of ARR in the second quarter, gave Amplitude a stronger answer to Optimizely and LaunchDarkly, and created a public link to OpenAI, reinforced when Statsig founder Vijaye Raji joined Amplitude's board in October 2026. The risk is customer churn during the handover.
Walnut is informational, not investment advice, and gives no verdict on AMPL. Analyst targets referenced here come from a October 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.